---
$id: https://graph.org.ai/products/commodity/51263158
$type: Product
source: UNSPSC
code: "51263158"
title: "Carteolol hydrochloride"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Carteolol hydrochloride

**UNSPSC Code**: 51263158
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C16H24N2O3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4797W6I0T4, chemically known as 2(1h)-quinolinone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro- but more generally known as carteolol hydrochloride, which bears US NIH Compound Identifier 2583. European Medicines Agency schedules Carteolol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13251MIG. Most nations, for tariff and trade purposes, schedule carteolol hydrochloride under HS 29337900 and SITC 51561. As of Q4 2014, CARTEOLOL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Carteolol hydrochloride bears US NLM identifiers UMLS ID C0543450 and NCI Concept Code C28905. SMILES: CC(C)(C)NCC(COC1CCCC2C1CCC(=O)N2)O.CL.

